RxDoctor Payments Data

Monica Gonzalez

Medical · Pharr, TXNPI 1962642777

Payments from drug & device makers

$454in general payments, 2019–2025

Across 24 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$135
  • Lilly USA, LLC$59
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$57
  • Otsuka America Pharmaceutical, Inc.$48
  • GSK$41
  • Novo Nordisk$38
  • plus $77 from 4 others

What the payments were for

  • Food & beverage$454100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$454 in reported general payments places this provider in the 40th percentile of 1,490 medical providers in Texas.

See all medical providers in Texas

Medicare billing

Part B allowed, 2024
$9,855
Medicare patients
22
Services billed
182

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide40$34,803
JanuviaSitagliptin Phosphate23$21,769
FarxigaDapagliflozin Propanediol18$20,491
LinzessLinaclotide20$17,217
JardianceEmpagliflozin16$16,953
TrulicityDulaglutide17$15,669
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,043
Dexlansoprazole DrDexlansoprazole16$2,994
Esomeprazole Magnesium14$1,745
Pregabalin17$1,202
Alcohol PadsAlcohol Antiseptic Pads14$1,200
Diclofenac Sodium25$1,095
Atorvastatin Calcium90$742
Metoprolol Succinate42$714
Famotidine49$709

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$38$34,80340 claims
AstraZenecaFarxiga$135$20,49118 claims
AbbVieLinzess$20$17,21720 claims
Lilly USA, LLCTrulicity$59$15,66917 claims
GSKTrelegy Ellipta$41$7,04311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,490 medical providers in Texas.

Other medical in Pharr

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →